Gerd-r Burmester
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients.
Journal: Journal of autoimmunity
Published: October 22, 2022
Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension.
Journal: Frontiers in immunology
Published: March 13, 2022
Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still's Disease and Active Articular Manifestation Responding to Canakinumab.
Journal: Journal of clinical medicine
Published: August 11, 2021
Selective depletion of plasma cells in vivo based on the specificity of their secreted antibodies.
Journal: European journal of immunology
Published: February 12, 2019
Do musculoskeletal ultrasound and magnetic resonance imaging identify synovitis and tenosynovitis at the same joints and tendons? A comparative study in early inflammatory arthritis and clinically suspect arthralgia.
Journal: Arthritis research & therapy
Published: October 04, 2018
Genomic stratification by expression of HLA-DRB4 alleles identifies differential innate and adaptive immune transcriptional patterns - A strategy to detect predictors of methotrexate response in early rheumatoid arthritis.
Journal: Clinical immunology (Orlando, Fla.)
Published: August 08, 2016
Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓ.
Journal: PloS one
Published: March 03, 2014
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study.
Journal: Annals of the rheumatic diseases
Published: June 29, 2012
Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.
Journal: Journal of autoimmunity
Published: May 17, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026